Immunisation of mares with binding domains of toxins A and B of Clostridium difficile elicits serum and colostral antibodies that block toxin binding

Equine Veterinary Journal

Volumn 45, Issue 4, 2013, Pages 476-480

  Artiushin, S ^a   Timoney, J F ^a   Fettinger, M ^a   Fallon, L ^b   Rathgeber, R ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b HAGYARD EQUINE MEDICAL INSTITUTE   (United States)

Author keywords

Clostridium difficile; Enterocolitis; Foal; Horse; Toxins; Vaccine

Indexed keywords

BACTERIAL TOXIN; BACTERIUM ANTIBODY; CHAPERONE; CLOSTRIDIUM DIFFICILE LETHAL TOXIN B; ENTEROTOXIN; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHEMISTRY; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COLOSTRUM; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HORSE; HORSE DISEASE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PREGNANCY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; PSEUDOMEMBRANOUS COLITIS;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; COLOSTRUM; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HORSE DISEASES; HORSES; MOLECULAR CHAPERONES; PREGNANCY; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

CLOSTRIDIUM DIFFICILE; EQUIDAE;

EID: 84878928302     PISSN: 04251644     EISSN: 20423306     Source Type: Journal    
DOI: 10.1111/evj.12007     Document Type: Article

References (34)

1. Ehrich, M., Perry, B., Troutt, H., Dellers, R. and Magnusson, R. (1984) Acute diarrhea in horses of the Potomac River area: examination for clostridial toxins. J. Am. Vet. Med. Ass. 185, 433-435.
2. Jones, R.L., Adney, W.S. and Shideler, R.K. (1987) Isolation of Clostridium difficile and detection of cytotoxin in the feces of diarrheic foals in the absence of antimicrobial treatment. J. Clin. Microbiol. 25, 1225-1227.
3. Jones, R., Adney, W., Alexander, A., Shideler, R. and Traub-Dargatz, J. (1988) Hemorrhagic necrotizing enterocolitis associated with Clostridium difficile infection in four foals. J. Am. Vet. Med. Ass. 193, 76-79.
4. Baverud, V., Gustafsson, A., Franklin, A., Lindholm, A. and Gunnarsson, A. (1997) Clostridium difficile associated with acute colitis in mature horses treated with antibiotics. Equine Vet. J. 29, 279-284.
5. Gustafsson, A., Baverud, V., Gunnarsson, A., Rantzien, M., Lindholm, A. and Franklin, A. (1997) The association of erythromycin ethylsuccinate with acute colitis in horses in Sweden. Equine Vet. J. 29, 314-318.
6. Magdesian, K., Madigan, J., Hirsh, D., Jang, S., Tang, Y. and Carpenter, T. (1997) Clostridium difficile and horses: a review. Rev. Med. Microbiol. 8, 48-48.
7. Baverud, V., Gustafsson, A., Franklin, A., Aspan, A. and Gunnarsson, A. (2003) Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility. Equine Vet. J. 35, 465-471.
8. Magdesian, K.G., Hirsh, D.C., Jang, S.S., Hansen, L.M. and Madigan, J.E. (2002) Characterization of Clostridium difficile isolates from foals with diarrhea: 28 cases (1993-1997). J. Am. Vet. Med. Ass. 220, 67-73.
9. Arroyo, L.G., Weese, J.S. and Staempfli, H.R. (2004) Experimental Clostridium difficile enterocolitis in foals. J. Vet. Intern. Med. 18, 734-738.
10. Arroyo, L.G., Staempfli, H. and Weese, J.S. (2007) Molecular analysis of Clostridium difficile isolates recovered from horses with diarrhea. Vet. Microbiol. 120, 179-183.
11. Medina-Torres, C.E., Weese, J.S. and Staempfli, H.R. (2011) Prevalence of Clostridium difficile in horses. Vet. Microbiol. 152, 212-215.
12. Voth, D.E. and Ballard, J.D. (2005) Clostridium difficile Toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18, 247-263.
13. Ward, S.J., Douce, G., Figueiredo, D., Dougan, G. and Wren, B.W. (1999) Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A. Infect. Immun. 67, 2145-2152.
14. Giannasca, P.J. and Warny, M. (2004) Active and passive immunization against Clostridium difficile diarrhea and colitis. Vaccine 22, 848-856.
15. Gardiner, D.F., Rosenberg, T., Zaharatos, J., Franco, D. and Ho, D.D. (2009) A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A. Vaccine 27, 3598-3604.
16. Greenberg, R.N., Marbury, T.C., Foglia, G. and Warny, M. (2012) Phase I dose finding studies of an adjuvanted Clostridium difficile toxoid vaccine. Vaccine 30, 2265-2269.
17. Lyerly, D.M., Bostwick, E.F., Binion, S.B. and Wilkins, T.D. (1991) Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect. Immun. 59, 2215-2218.
18. Giannasca, P.J., Zhang, Z., Lei, W., Boden, J.A., Giel, M.A., Monath, T.P. and Thomas, W.D., Jr. (1999) Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters. Infect. Immun. 67, 527-538.
19. Taylor, C.P., Tummala, S., Molrine, D., Davidson, L., Farrell, R.J., Lembo, A., Hibberd, P.L., Lowy, I. and Kelly, C.P. (2008) Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A. Vaccine 26, 3404-3409.
20. Hedges, J.F., Demaula, C.D., Moore, B.D., McLaughlin, B.E., Scott, I.S. and MacLauchlan, N.J. (2001) Characterization of equine E-selectin. Immunology 103, 498-504.
21. Maguire, L.C. (1958) The role of Bacterium viscosum equi in the causation of equine disease. Vet. Rec. 70, 989-991.
22. Powell, D., Dwyer, R., Traub-Dargatz, J., Fulker, R., Whalen, J.J., Srinivasappa, J., Acree, W. and Chu, H. (1997) Field study of the safety, immunogenicity, and efficacy of an inactivated equine rotavirus vaccine. J. Am. Vet. Med. Ass. 211, 193-198.
23. Timoney, J., Hartmann, M., Fallon, L., Fallon, E. and Walker, J. (2005) Antibody responses of mares to prepartum vaccination with Clostridium perfringens bacterin and beta2 toxin. Vet. Rec. 17, 810-812.
24. Skaggs, J.S., Reed Holyoak, G., Montelongo, M., Ayalew, S. and Confer, A.W. (2011) Serum antibody responses in horses and mice following immunization with Actinobacillus equuli outer membrane proteins and recombinant Aqx toxin. Vet. J. 190, e91-e94.
25. Sheoran, A., Karzenski, S., Whalen, J., Crisman, M., Powell, D. and Timoney, J. (2000) Prepartum equine rotavirus vaccination inducing strong specific IgG in mammary secretions. Vet. Rec. 146, 672-673.
26. Sheoran, A., Timoney, J., Holmes, M., Karzenski, S. and Crisman, M. (2000) Immunoglobulin isotypes in sera and nasal mucosal secretions and their neonatal transfer and distribution in horses. Am. J. Vet. Res. 61, 1099-1105.
27. Kyne, L., Warny, M., Qamar, A. and Kelly, C.P. (2000) Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A. N. Engl. J. Med. 342, 390-397.
28. East, L., Savage, C., Traub-Dargatz, J., Dickinson, C. and Ellis, R. (1998) Enterocolitis associated with Clostridium perfringens infection in neonatal foals: 54 cases (1988-1997). J. Am. Vet. Med. Ass. 212, 1751-1756.
29. Jones, R. (2000) Clostridial enterocolitis. Vet. Clin. N. Am.: Equine Pract. 16, 471-485.
30. Baverud, V., Franklin, A., Gunnarsson, A., Gustafsson, A. and Hellander-Edman, A. (1998) Clostridium difficile associated with acute colitis in mares when their foals are treated with erythromycin and rifampicin for Rhodococcus equi pneumonia. Equine Vet. J. 30, 482-488.
31. Ananthakrishnan, A.N. (2011) Clostridium difficile infection: epidemiology, risk factors and management. Nat. Rev. Gastroenterol. Hepatol. 8, 17-26.
32. Roberts, A., McGlashan, J., Al-Abdulla, I., Ling, R., Denton, H., Green, S., Coxon, R., Landon, J. and Shone, C. (2012) Development and evaluation of an ovine antibody-based platform for treatment of Clostridium difficile infection. Infect. Immun. 80, 875-882.
33. Keel, K., Brazier, J.S., Post, K.W., Weese, S. and Songer, J.G. (2007) Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J. Clin. Microbiol. 45, 1963-1964.
34. Blake, J.E., Mitsikosta, F. and Metcalfe, M.A. (2004) Immunological detection and cytotoxic properties of toxins from toxin A-positive, toxin B-positive Clostridium difficile variants. J. Med. Microbiol. 53, 197-205.